Bausch Health Announces Thomas J. Appio As Chief Executive Officer

LAVAL, QC, May perhaps 6, 2022 /PRNewswire/ — Bausch Wellness Organizations Inc. (NYSE/TSX: BHC) (Bausch Well being) right now announced its total management crew and Board of Administrators, which include Main Executive Officer (CEO) Thomas J. Appio.¹ Upon completion of the first public supplying (IPO) of the Bausch + Lomb eye health company,² former CEO Joseph C. Papa will suppose the purpose of chairman and CEO of Bausch + Lomb.

“It is an honor and privilege to lead Bausch Wellbeing at this pivotal time in its background, and I am thrilled for our upcoming,” said Mr. Appio. “We are a global specialty pharmaceutical firm with deep knowledge in gastroenterology, hepatology, neurology, dermatology and global prescription drugs serving sufferers for more than 60 yrs.”

“As we get started running as a separate organization, we will leverage our industrial abilities to increase obtain to our therapies and expand our market place arrive at, and we will commit in innovation and new business enhancement to establish a long run product or service pipeline to deal with unmet requirements. I glance forward to top our talented crew of 7,000 world wide staff towards the exciting alternatives ahead,” continued Mr. Appio.

The Bausch Wellbeing executive management crew, which is comprised of knowledgeable leaders with several years of knowledge in their respective areas, incorporates:

• Thomas J. Appio, Main Government Officer
• Thomas (Tom) Vadaketh, Executive Vice President, Chief Monetary Officer
• Seana Carson, Govt Vice President, Standard Counsel
• Mirza Dautbegovic, Senior Vice President, Chief Running Officer
• Kathleen Fitzpatrick, Senior Vice President, Chief Human Means Officer
• Jeff Hartness, Senior Vice President, Marketplace Entry, Commercial Functions & Authorities Affairs
• Cees Heiman, Senior Vice President, Europe and Canada
• Graham Jackson, Senior Vice President, Main Quality Officer
• Tage Ramakrishna, M.D., Chief Health care Officer and President of R&D
• Robert Spurr, President of the U.S. business
• Fernando Zarate, Vice President, Latin America

In addition to the appointment of Mr. Appio as CEO and a member of the Board of Directors, Richard Mulligan, Ph.D., will be appointed to the Bausch Health and fitness Board of Directors.

Dr. Mulligan is presently the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical University, right after serving as the Mallinckrodt Professor of Genetics and director of the Harvard Gene Remedy Initiative from 1996 to 2013. He also serves as government vice chairman of the Board of Sana Biotechnology, Inc. From March 2017 to October 2018, he served as a portfolio supervisor at Icahn Funds LP. Prior to that, he was a professor of Molecular Biology at the Massachusetts Institute of Technology, a member of the Whitehead Institute for Biomedical Research and chief scientific officer of Somatix Remedy Corporation, a drug discovery and progress firm that he established. Dr. Mulligan was a founding associate of Sarissa Cash Management LP from 2013 to 2016. He was named a MacArthur Foundation Fellow in 1981.

Mr. Papa will stay in the function of chairman of the Board of Administrators for Bausch Overall health till the comprehensive separation of Bausch + Lomb, at which time Robert N. Electric power will thrive as chairman.

On completion of the IPO, the Bausch Wellbeing Board of Directors will consist of the next folks:

• Joseph C. Papa, Chairman
• Robert N. Energy
• Thomas J. Appio
• Richard U. DeSchutter
• Brett Icahn
• Argeris (Jerry) N. Karabelas, Ph.D.
• Sarah B. Kavanagh
• Steven D. Miller
• Richard Mulligan, Ph.D.
• Russel C. Robertson
• Thomas W. Ross, Sr.
• Amy B. Wechsler, M.D.

For extra details about the firm’s management and Board of Directors, please pay a visit to www.bauschhealth.com.

Bausch Well being will keep on to be headquartered in Laval, Quebec, and will continue on to trade on the New York Stock Exchange and Toronto Inventory Trade underneath its current symbol, “BHC”.

Bausch Well being Companies Inc. (NYSE/TSX: BHC) is a world-wide diversified pharmaceutical company whose mission is to strengthen people’s life with our health treatment solutions. We produce, manufacture and market place a range of items generally in gastroenterology, hepatology, neurology, dermatology and global prescription drugs. With our primary long lasting models, we are offering on our commitments as we make an revolutionary company committed to advancing international overall health. For extra data, go to www.bauschhealth.com and link with us on Twitter and LinkedIn.

This information launch may possibly have forward-on the lookout statements, inside the this means of relevant securities legislation (collectively, “ahead-wanting statements”), including, but not constrained to, statements respecting the appointment of specified management staff users and the predicted successful day of this sort of appointments and statements about the completion of the preliminary general public providing (IPO) of Bausch + Lomb and the full separation of Bausch + Lomb. Ahead-on the lookout statements might usually be recognized by the use of the words and phrases “anticipates,” “hopes,” “expects,” “intends,” “ideas,” “should,” “could,” “would,” “may,” “will,” “thinks,” “estimates,” “likely,” “goal,” or “continue on” and variants or comparable expressions, and phrases or statements that specific steps, functions or results may possibly, could, ought to or will be achieved, received or taken, or will manifest or end result, and similar these expressions also determine ahead-searching information and facts. These ahead-wanting statements are based mostly upon the recent anticipations and beliefs of management and are offered for the function of supplying added facts about this kind of anticipations and beliefs, and viewers are cautioned that these statements may not be proper for other needs. These forward-searching statements are matter to certain threats and uncertainties that could cause real effects to vary materially from people explained in the ahead-looking statements. These risks and uncertainties contain, but are not restricted to, the risks and uncertainties talked about in the Bausch Health’s most latest annual and quarterly stories and thorough from time to time in Bausch Health’s other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Directors, which challenges and uncertainties are incorporated herein by reference. These hazards and uncertainties also involve, but are not restricted to, the hazards relating to the completion of the IPO transaction, like owing to unfavorable sector or other ailments or elements the risk that the other approvals for or conditions to the completion of the transaction are not acquired or contented on a timely foundation or at all adjustments in the anticipated timing for closing the transaction business disruption in the course of the pendency of or pursuing the transaction diversion of administration time on transaction-associated challenges the capability to retain Bausch + Lomb management workforce associates threats associated to the response of prospects and other functions to these transaction the impact of these transaction on interactions with shoppers, suppliers, personnel and other organization counterparties the danger that the proposed distribution of Bausch + Lomb widespread shares to Bausch Health’s shareholders does not occur in the fashion or on the timelines expected or at all and other activities that could adversely impact the completion of the transaction, including business or financial problems outside the house of Bausch Health’s control. In particular, Bausch Well being can present no assurance that any distribution will manifest at all, or that any these transaction or transactions will manifest on the timelines, in the manner or on the terms anticipated by Bausch Overall health. They also consist of, but are not constrained to, hazards and uncertainties caused by or relating to the COVID-19 pandemic, such as a doable resurgence of the virus and variant strains thereof and its effects on accessibility to overall health treatment items and products and services, the availability and use of helpful vaccines, the imposition of new social limitations, disruptions in Bausch Health’s supply chain and distribution channels or the ongoing macroeconomic and health and fitness care restoration from the impacts of the COVID-19 pandemic. In addition, specified material aspects and assumptions have been applied in building these forward-looking statements, including the assumption that the hazards and uncertainties outlined over will not trigger precise effects or gatherings to vary materially from individuals described in these ahead-looking statements.

Bausch Health believes that the material elements and assumptions mirrored in these ahead-on the lookout statements are realistic in the situations, but viewers are cautioned not to place undue reliance on any of these ahead-wanting statements. These ahead-on the lookout statements discuss only as of the day hereof. Bausch Well being undertakes no obligation to update any of these ahead-searching statements to replicate events or situation just after the date of this information release or to mirror genuine results, unless necessary by regulation.

¹ All management and board appointments are conditional and powerful on the closing of the IPO of Bausch + Lomb.
² The widespread shares have been authorized for listing on the New York Inventory Exchange (“NYSE”) and conditionally authorized for listing on the Toronto Inventory Exchange (“TSX”). The common shares start out trading on the NYSE and on an “if, as and when issued foundation” on the TSX on May well 6, 2022 and the IPO is expected to near on Could 10, 2022, subject matter to customary closing conditions.

See primary information to obtain multimedia:

Resource Bausch Overall health Companies Inc.

The over push launch was delivered courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Grey Media Group nor do they always condition or replicate all those of Gray Media Group, Inc.